|
LRRC57 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.054200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.204600E-01 |
| Normal-vs-Stage2 |
6.529200E-01 |
| Normal-vs-Stage3 |
1.615810E-01 |
| Normal-vs-Stage4 |
1.263580E-01 |
| Stage1-vs-Stage2 |
7.265200E-01 |
| Stage1-vs-Stage3 |
1.710370E-01 |
| Stage1-vs-Stage4 |
1.277210E-01 |
| Stage2-vs-Stage3 |
5.542200E-01 |
| Stage2-vs-Stage4 |
4.658200E-01 |
| Stage3-vs-Stage4 |
8.033800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.049800E-01 |
| Normal-vs-AfricanAmerican |
1.270200E-01 |
| Normal-vs-Asian |
8.324400E-01 |
| Caucasian-vs-AfricanAmerican |
3.135500E-02 |
| Caucasian-vs-Asian |
4.906000E-01 |
| AfricanAmerican-vs-Asian |
1.717850E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.384800E-01 |
| Normal-vs-Female |
4.974200E-01 |
| Male-vs-Female |
6.254600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.514800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.666160E-01 |
| Normal-vs-Age(61-80Yrs) |
6.967800E-01 |
| Normal-vs-Age(81-100Yrs) |
3.843000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.578220E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.287000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.574800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.471800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.768200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.545200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.983980E-01 |
| Classical-VS-Follicular |
2.387200E-01 |
| Classical-VS-Other |
7.071200E-01 |
| Classical-VS-Normal |
4.814000E-01 |
| Tall-VS-Follicular |
4.468500E-02 |
| Tall-VS-Other |
7.719000E-01 |
| Tall-VS-Normal |
7.673600E-02 |
| Follicular-VS-Other |
5.452000E-01 |
| Follicular-VS-Normal |
5.605000E-01 |
| Other-VS-Normal |
4.889200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.681200E-01 |
| Normal-vs-N1 |
3.213900E-02 |
| N0-vs-N1 |
4.880000E-02 |
|
|
